Treatment of <i>Candida glabrata</i> Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin
ABSTRACT While Candida albicans remains the most common Candida isolate, Candida glabrata accounts for approximately 15 to 20% of all Candida infections in the United States. In this study we used immunosuppressed mice infected with C. glabrata to investigate the efficacy of liposomal amphotericin B...
保存先:
主要な著者: | Jon Olson, Jill Adler‐Moore, Peter J. Smith, Richard T. Proffitt |
---|---|
フォーマット: | Artigo |
言語: | 英語 |
出版事項: |
2005
|
オンライン・アクセス: | https://doi.org/10.1128/aac.49.12.4895-4902.2005 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
-
Treatment of Candida glabrata Infection in Immunosuppressed Mice by Using a Combination of Liposomal Amphotericin B with Caspofungin or Micafungin
著者:: Olson, Jon A., 等
出版事項: (2005) -
Caspofungin in Combination with Amphotericin B against Candida glabrata
著者:: Barchiesi, Francesco, 等
出版事項: (2005) -
Killing Kinetics of Caspofungin, Micafungin, and Amphotericin B against Candida guilliermondii
著者:: Cantón, Emilia, 等
出版事項: (2006) -
Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report
著者:: Yamada, Shoko Merrit, 等
出版事項: (2016) -
Candida glabrata Mutants Demonstrating Paradoxical Reduced Caspofungin Susceptibility but Increased Micafungin Susceptibility
著者:: Healey, Kelley R., 等
出版事項: (2011)